Medivir licenses HCV drug MIV802 to Chinese Ascletis

Medivir licenses HCV drug MIV-802 to Chinese Ascletis

12:07 EST 16 Jan 2019 | European Biotechnology News

Original Article: Medivir licenses HCV drug MIV-802 to Chinese Ascletis

More From BioPortfolio on "Medivir licenses HCV drug MIV-802 to Chinese Ascletis"